Literature DB >> 6410741

Comparative double-blind investigation of meglumine metrizoate, metrizamide, and iohexol in carotid angiography.

T Hindmarsh, G Bergstrand, K Ericson, H Olivecrona.   

Abstract

The new nonionic contrast medium iohexol (Omnipaque) was compared with its predecessor metrizamide (Amipaque) and with the conventional ionic medium meglumine metrizoate (Isopaque Cerebral) in carotid angiography using a double-blind crossover technique. The results indicated that iohexol and metrizamide caused less discomfort than the ionic medium. The circulatory effects of the three media were generally mild, and the diagnostic effectiveness was comparable when the iodine concentration was kept in the range of 280-300 mg I/ml.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6410741      PMCID: PMC8334991     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  2 in total

1.  Digital subtraction angiography (DSA). Work load and financial implications for a neuroradiology department.

Authors:  D P Kingsley; P Butler; G M Rowe; R C Travis; I G Wylie
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

2.  Comparison of iohexol 300 mg I/ml and Hexabrix 320 mg I/ml in central angiography. A double-blind trial.

Authors:  J Valk; F Crezée; R G Olislagers-de Slegte
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.